Two wavelengths, one session — why it matters

Glance at the Regen PhD Pod's specification sheet and two numbers stand out: 660 nm and 850 nm. The natural question is why both — and whether one would do.

The short answer is that the body is not uniform in depth. Red light at 660 nm is absorbed within the epidermis and dermis, roughly 8–10 mm beneath the surface. Near-infrared at 850 nm travels considerably further — reported up to approximately 5 cm — reaching hypodermis, muscle, tendon, and joint tissue that red light cannot reliably access. Run one wavelength alone and you serve either the surface or the deeper structures, not both.

The Pod delivers the two wavelengths concurrently, in a single session. That choice reflects the engineering logic at the heart of Professor Paul Lee's Regeneration by Design: physical energies should be applied systemically and simultaneously, not as isolated, sequential inputs.

The sections that follow explain what each wavelength does at the cellular level, why they share a common biological mechanism despite reaching different depths, and what simultaneous delivery is designed to achieve.

The shared cellular engine: mitochondria and cytochrome c oxidase

Beneath the wavelength numbers sits a single protein that both frequencies target — and understanding it clarifies why photobiomodulation is described as a cellular rather than purely a surface phenomenon.

Mitochondria generate adenosine triphosphate (ATP), the molecule cells use as their immediate energy currency. Sitting at the end of the mitochondrial electron transport chain is cytochrome c oxidase (CCO), also known as Complex IV. Research across PubMed and Frontiers in Neuroscience identifies CCO as the major intracellular acceptor of photons in the red-to-near-infrared range used for photobiomodulation — essentially, it acts as a biological light receiver.

The dominant mechanistic model runs as follows: a photon is absorbed by CCO, displacing a molecule of nitric oxide that was partially inhibiting the enzyme. With that brake lifted, electron transport proceeds more freely, the mitochondrial proton gradient steepens, and ATP synthase produces energy more efficiently. Research also points to transient, beneficial changes in reactive oxygen species and intracellular calcium as secondary signals that may support cell proliferation and repair.

It is worth noting that a minority of researchers question whether CCO is the primary photon acceptor specifically at NIR frequencies, suggesting the mechanistic picture may yet be refined. The science remains active. Within the photobiomodulation literature, however, the CCO cascade is the established working model — and it is the mechanism the Regen PhD Pod's light modality is designed to support.

What differs between 660 nm and 850 nm is not this shared pathway, but how far through tissue each wavelength travels before its photons are absorbed — which determines which structures benefit most.

Red light at 660 nm: precision at the surface

Red light sits at the warm, visible end of the spectrum — and its visibility is a clue to its behaviour in tissue. At 660 nm, photons are absorbed readily by melanin and haemoglobin in the skin's upper layers, which means they deposit their energy shallowly: roughly 8–10 mm, spanning the epidermis and upper dermis. This is not a deficiency of the wavelength; it is precisely where the cells that govern skin structure live.

Fibroblasts — the connective-tissue cells responsible for producing collagen, elastin, and hyaluronic acid — are concentrated in this dermal zone. Research in this area suggests that red-light exposure may stimulate fibroblast proliferation and upregulate the synthesis pathways for those structural proteins. Regen PhD positions 660 nm as designed to support collagen signalling and skin-tone at the surface, with the same cytochrome c oxidase mechanism described in the preceding section driving the cellular response — just at shallower depth.

The same wavelength anchors Regen PhD's LED Facial add-on, which layers 660 nm and 850 nm specifically for facial regeneration. That product architecture reflects a deliberate choice: 660 nm has a defined, bounded role — surface-layer cellular signalling — rather than being a generic 'light therapy' setting. It is worth noting that some PBM devices have received FDA clearance for certain dermal indications, though the Pod itself is a non-medical wellness product designed to support general skin wellbeing and recovery rather than to treat any condition.

Near-infrared at 850 nm: reaching deeper into the body

Nudging the wavelength just beyond the visible red boundary changes the physics considerably. At 850 nm, light is no longer detectable by the human eye, but it scatters less in biological tissue than shorter wavelengths do — which allows it to carry photon energy significantly further before being absorbed. Reported penetration depths reach approximately 5 cm, placing the hypodermis, skeletal muscle, fascia, tendon, and joint capsule within range.

This matters because those deeper tissues are metabolically demanding. Skeletal muscle relies heavily on mitochondrial ATP output during both effort and recovery; connective tissues including tendon and joint capsule depend on adequate cellular energy for structural maintenance. The same cytochrome c oxidase mechanism described in section 2 operates in these cells — but they sit well beyond the 8–10 mm reach of 660 nm red light. NIR is not a different process; it is the same process applied at a different address.

Microcirculation is another area of research interest at NIR wavelengths. Improved local blood flow to deeper structures may support nutrient delivery and the clearance of metabolic by-products after physical demand.

On the longevity angle, a 2022 study published in Frontiers in Neuroscience found that 58 days of transcranial PBM at 810 nm reversed age-related declines in CCO activity in rat brains, restoring levels comparable to young animals. This is compelling adjacent evidence — but it is animal-model research only, and human equivalence has not been established.

Regen PhD positions 850 nm as supporting mitochondrial repair and structural recovery at depth — a logical complement to 660 nm's surface role. If red handles the skin matrix, NIR reaches the tissue underneath: two wavelengths, one shared mechanism, two distinct targets.

Why delivering both together changes what's possible

Think of a single limb in cross-section: epidermis and dermis occupy the first centimetre, then subcutaneous fat, then skeletal muscle, tendon, and joint. A session delivering only 660 nm addresses the surface layers; one delivering only 850 nm reaches the deeper structures but leaves the skin matrix largely unstimulated. Neither wavelength alone covers the full vertical range of tissue that stands to benefit from photon-driven ATP support.

Running both concurrently closes that gap. Surface and deep tissues are addressed within the same session window, with no need to alternate or sequence separate treatments targeting one layer at a time. This is not an additive design decision — it is a logical one: the two wavelengths are complementary because the tissues they serve occupy different anatomical depths.

Modern photobiomodulation panels increasingly pair red and NIR for precisely this coverage rationale, and the Pod's dual-wavelength protocol reflects that evidence-based engineering approach. The whole-body format extends the logic further: rather than treating a discrete patch of skin or a single joint, surface and deep tissues across the full body are addressed at once.

Every session's combined light output is captured within the R.E.U. (Regen Energy Unit) framework — the system Professor Paul Lee built into the Pod to measure and track total energy delivered across all five concurrent modalities. That consistency of dosing is what allows repeated sessions to build on one another rather than produce isolated, one-off stimulus.

The Physics pillar and building it into a rhythm

All of this sits within a deliberate intellectual structure. In Regeneration by Design, published in July 2024, Professor Paul Lee — regenerative orthopaedic surgeon and founder of Regen PhD — introduces Physics as the first of four interdependent pillars governing healthspan. The pillar encompasses the physical energies that interact with biological machinery: heat, light, vibration, and electromagnetic fields. Photobiomodulation belongs here not as a bolt-on treatment but as a first-principles input — photons acting on cellular receptors, shifting the mitochondrial environment at scale.

The whole-body Pod format follows directly from that logic. Where spot-treatment devices address a patch of skin or a single joint in isolation, the Physics pillar is conceived systemically: physical energies applied across the body to support repair in a coordinated way, alongside the Chemistry, Biology, and Time pillars, rather than in isolation from them.

The mechanistic story in the preceding sections only delivers its value through repetition. The Pod's guidance points to a minimum of around six sessions, used once or twice weekly, as the basis for cumulative effect. A first session is a stimulus; a consistent rhythm is where the design intent is realised.

Wellness note: the Regen PhD Pod is a non-medical wellness product, designed to support recovery, relaxation, and general wellbeing. It is not intended to diagnose, treat, or cure any medical condition. Anyone with health concerns should consult a qualified healthcare professional.